ATLANTA, Nov. 20 CryoLife, Inc. (NYSE: CRY), abiomaterials, medical device and tissue processing company, announced todaythat it is scheduled to participate in the 19th Annual Piper Jaffray HealthCare Conference at the Pierre Hotel in New York City on Tuesday, November 27,2007.
Steven G. Anderson, president and CEO of CryoLife, Inc. will deliver theCompany's presentation beginning at approximately 1:30 p.m. EST.
CryoLife's live presentation may be accessed through its Web site,www.cryolife.com, on the Investor Relations page. An archived copy of thepresentation will be available for 30 days on the same Web site.
Founded in 1984, CryoLife, Inc. is a leader in the processing anddistribution of implantable living human tissues for use in cardiac andvascular surgeries throughout the United States and Canada. The Company'sBioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures andstaples for use in adult patients in open surgical repair of large vessels.BioGlue is also CE marked in the European Community and approved in Canada andAustralia for use in soft tissue repair. The Company also distributes theCryoLife-O'Brien(R) stentless porcine heart valve, which is CE marked fordistribution within the European Community.
For additional information about the Company, visit CryoLife's Web Site:http://www.cryolife.com.Media Contacts: D. Ashley Lee Executive Vice President, Chief Financial Officer and Chief Operating Officer Phone: 770-419-3355 Katie Brazel Fleishman Hillard Phone: 404-739-0150
SOURCE CryoLife, Inc.